Commercial-stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer.

Sectors
Healthcare
Life Sciences
First Invested
2016
Public/PIPES
Company Status
IPO/Acquired
NASDAQ: AVEO
Acquired by LG Chem
Associated Team
Paul Walker